Cutaneous lichenoid drug eruptions: A narrative review evaluating demographics, clinical features and culprit medications
JT Maul, C Guillet, A Oschmann… - Journal of the …, 2023 - Wiley Online Library
Cutaneous lichenoid drug eruptions (LDE) are adverse drug reactions (ADR) characterized
by symmetric, erythematous, violaceous papules reminiscent but rarely fully characteristic of …
by symmetric, erythematous, violaceous papules reminiscent but rarely fully characteristic of …
[PDF][PDF] 外用中药成功治疗克唑替尼所致手足综合征2 例
裴育莹， 李锘， 贾立群， 娄彦妮 - 药物不良反应杂志, 2020 - cadrj.com
2 例患者(例1 女, 60 岁; 例2 男, 62 岁) 均因间变性淋巴瘤激酶基因阳性非小细胞肺癌给予口服
靶向药物克唑替尼治疗(剂量分别为250 mg, 2 次/d 和500 mg, 1 次/d). 2 例患者均于治疗半年后 …
靶向药物克唑替尼治疗(剂量分别为250 mg, 2 次/d 和500 mg, 1 次/d). 2 例患者均于治疗半年后 …
Cutaneous sarcoid‐like drug reaction caused by an anaplastic lymphoma kinase inhibitor
CA Gleue, K Shah, A Wentworth… - Journal of Cutaneous …, 2021 - Wiley Online Library
Anaplastic lymphoma kinase (ALK) rearranged lung cancers represent 4% to 6% of all
pulmonary adenocarcinomas, and echinoderm microtubule associated protein like 4 (EML4) …
pulmonary adenocarcinomas, and echinoderm microtubule associated protein like 4 (EML4) …
Photosensitivity associated with anaplastic lymphoma kinase inhibitors: A review of postmarketing cases reported to FDA and published in the literature.
C Cheng, A Nayernama, SC Jones… - Photodermatology …, 2023 - search.ebscohost.com
Keywords: anaplastic lymphoma kinase (ALK); brigatinib; ceritinib; crizotinib; photosensitivity
EN anaplastic lymphoma kinase (ALK) brigatinib ceritinib crizotinib photosensitivity 285 290 …
EN anaplastic lymphoma kinase (ALK) brigatinib ceritinib crizotinib photosensitivity 285 290 …
Crizotinib-induced oral lichenoid lesions
V Sibaud, NP Gomes, C Raspaud… - Indian Journal of …, 2020 - ijdvl.com
Sir, Crizotinib is a first‑generation orally active anaplastic lymphoma kinase (ALK) inhibitor,
also targeting mesenchymal‑epithelial transition factor (MET) receptor and receptor of …
also targeting mesenchymal‑epithelial transition factor (MET) receptor and receptor of …
Crizotinib-induced severe photosensitive dermatitis in a carcinoma lung patient
TP Afra, PP Nair, NTK Thanseer… - Indian Dermatology …, 2021 - journals.lww.com
Dear Editor, Newer personalized, genotype directed therapy has revolutionized the
treatment strategy for advanced malignancies given its specificity, superior efficacy, and less …
treatment strategy for advanced malignancies given its specificity, superior efficacy, and less …
Relevance of sun safety in patients commencing crizotinib for non‐small cell lung cancer.
S Heynemann, P Mitchell - Australasian Journal of …, 2021 - search.ebscohost.com
Relevance of sun safety in patients commencing crizotinib for non-small cell lung cancer Six
months after commencing crizotinib, towards the end of summer, the patient developed a …
months after commencing crizotinib, towards the end of summer, the patient developed a …